Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
SynopsisH

Several Chinese herbal products may contain toxic aristolochic acid

Eric Wooltorton
CMAJ August 31, 2004 171 (5) 449; DOI: https://doi.org/10.1503/cmaj.1041266
Eric Wooltorton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Reason for posting: Aristolochic acid, a naturally occurring herbal toxin that can cause cancer and end-stage kidney failure, has been the subject of warnings since 1999 from several international regulatory agencies. Canadian manufacturers, importers and retailers were directed in 2001 to remove all herbal products containing aristolochic acid from their shelves.1 However, Health Canada recently reissued a warning that consumers avoid such products2 amid concerns that the products are still widely available through the Internet.3 The Hong Kong Department of Health also recently published a list of specific brands of Chinese medicines known to contain aristolochic acid that should not be consumed (available in an online appendix at www.cmaj.ca/cgi/content/full/171/5/449/DC1).

The drug: Evidence of aristolochic acid's toxicity in animals has accumulated since the 1980s. Its toxicity in humans received widespread attention 4 years ago when a case series was published describing urinary tract cancers, nephropathy and renal failure in more than 100 women in Belgium who had taken weight-reducing pills containing aristolochic acid.4 Aristolochic acid, which is among the most potent 2% of carcinogens known,3 is derived principally from plants of the genus Aristolochia but may also be found in products containing several other botanicals (Box 1). Natural health products containing aristolochic acid are often sold as traditional Chinese medicines meant to effect weight loss, improve the immune system or alleviate gastrointestinal symptoms, menstrual complaints, cough and allergies. As with most herbal products, there is little and often no evidence from clinical trials of their efficacy for any of these benefits. No adverse effects related to aristolochic acid exposure have yet been reported in Canada.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Box 1.

What to do: Language barriers may prevent many health care practitioners from effectively verifying the ingredients listed on many Chinese herbal products. Instead, patients using Chinese herbal products should be warned to ensure that the products they are using do not contain the ingredients in question (Box 1) and are not one of the brands that have been recalled (see online appendix). Patients with suspected exposure to aristolochic acid should be monitored for signs of urinary tract tumours and nephropathy.

Eric Wooltorton CMAJ

References

  1. 1.↵
    Health Canada advises consumers about additional products that could contain aristolochic acid. Ottawa: Health Canada; 2001 Oct 5. Available: www.hc-sc.gc.ca/english/protection/warnings/2001/2001_105e.htm (accessed 2004 Aug 5).
  2. 2.↵
    Health Canada advises consumers not to use the products containing aristolochic acid. Ottawa: Health Canada; 2004 July 26. Available: www.hc-sc.gc.ca/english/protection/warnings/2004/2004_43.htm (accessed 2004 Aug 5).
  3. 3.↵
    Gold LS, Slone TH. Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert [letter]. N Engl J Med 2003;349:1576-7.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342: 1686-92.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 171 (5)
CMAJ
Vol. 171, Issue 5
31 Aug 2004
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Several Chinese herbal products may contain toxic aristolochic acid
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Several Chinese herbal products may contain toxic aristolochic acid
Eric Wooltorton
CMAJ Aug 2004, 171 (5) 449; DOI: 10.1503/cmaj.1041266

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Several Chinese herbal products may contain toxic aristolochic acid
Eric Wooltorton
CMAJ Aug 2004, 171 (5) 449; DOI: 10.1503/cmaj.1041266
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The changing ecology of avian flu
  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Drugs: adverse reactions

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire